Approval · Notice of Compliance 16743 · 2015
EDARBI: Notice of Compliance 16743
Issued March 25, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 16743
- Date
- March 25, 2015
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Transfer of drug identification number
- Therapeutic class
- Angiotensin II at1 receptor blocker
Products in this notice
Medicinal ingredients
- AZILSARTAN MEDOXOMIL 40 MG per TAB
- AZILSARTAN MEDOXOMIL 80 MG per TAB